abstract |
Described are 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines compounds of formula 1, for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases in which blockade of the voltage-dependent sodium channel may be of therapeutic value. |